يعرض 1 - 10 نتائج من 26 نتيجة بحث عن '"Lopes, Ana Beatriz Pascoal"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia

    المؤلفون: Braga, Arthur Gomes Oliveira, Barbosa Pagnano, Katia Borgia, Campioni, Marina Dal'Bó Pelegrini, Lopes, Ana Beatriz Pascoal, Duarte, Gislaine Oliveira, Metze, Konradin, Lorand-Metze, Irene

    المصدر: In Hematology, Transfusion and Cell Therapy July-September 2024 46(3):268-272

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Metabolic shift of chronic myeloid leukemia patients under imatinib–pioglitazone regimen and discontinuation

    المؤلفون: Póvoa, Valquíria Mariane OliveiraAff1, Aff2, Delafiori, Jeany, Dias-Audibert, Flávia Luísa, de Oliveira, Arthur Noin, Lopes, Ana Beatriz Pascoal, de Paula, Erich Vinícius, Pagnano, Katia Borgia BarbosaAff1, Catharino, Rodrigo RamosAff2

    المصدر: Medical Oncology. 38(9)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  4. 4
    Evaluation of gene and protein expression of the PPAR-gamma/STAT5 pathway in the pilot study of discontinuation of imatinib in patients with chronic myeloid leukemia with deep molecular response (EDI-PIO)

    المؤلفون: Lopes, Ana Beatriz Pascoal, 1995

    المساهمون: Pagnano, Katia Borgia Barbosa, Bendit, Israel, Vigorito, Afonso Celso, Programa de Pós-Graduação em Clínica Médica, UNIVERSIDADE ESTADUAL DE CAMPINAS

    المصدر: Biblioteca Digital de Teses e Dissertações da Universidade Estadual de Campinas (UNICAMP)
    Universidade Estadual de Campinas (UNICAMP)
    instacron:UNICAMP

    مصطلحات موضوعية: Fator de transcrição STAT5, Pioglitazone, PPAR-gamma, Imatinibe, Chronic myeloid leukemia, Imatinib, Leucemia mielóide crônica, PPAR gama, STAT5 transcription factor, Pioglitazona

    وصف الملف: application/pdf; 1 recurso online (74 p.) : il., digital, arquivo PDF.

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3056::12bea46d50ba60ea39b112cb7ec2fb19

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure

    المؤلفون: Perusini, Maria Agustina *, Pagnano, Katia B, Pavlovsky, Carolina *, Moiraghi, Beatriz *, Varela, Ana Ines *, Bianchini, Michele *, Mayer, Jiří, Žácková, Daniela *, Kvetková, Anežka *, Jurček, Tomáš *, Ježíšková, Ivana *, Lopes, Ana Beatriz Pascoal *, Duarte, Gislaine B O *, Souza, Carmino Antonio *, Medeiros, Jessie J.F., Kim, Taehyung Simon *, Yoo, Young Seok *, Kim, Kyoung Ha, Lee, Hye Won *, Chang, Myung Hee *, Yi, Seong Yoon *, Abelson, Sagi *, Kim, Dennis

    المصدر: In Blood 15 November 2022 140 Supplement 1:6782-6783

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy

    المؤلفون: Perusini, Maria Agustina *, Kim, Taehyung Simon *, Žácková, Daniela *, Pagnano, Katia B, Mayer, Jiří, Pavlovsky, Carolina *, Ježíšková, Ivana *, Kvetková, Anežka *, Jurček, Tomáš *, Moiraghi, Beatriz *, Varela, Ana Ines *, Bianchini, Michele *, Lopes, Ana Beatriz Pascoal *, Duarte, Gislaine B O *, Yoo, Young Seok *, Souza, Carmino Antonio *, Medeiros, Jessie *, Lee, Hye Won *, Kim, Kyoung Ha, Yi, Seong Yoon *, Chang, Myung Hee *, Abelson, Sagi *, Kim, Dennis Dong Hwan

    المصدر: In Blood 15 November 2022 140 Supplement 1:6774-6775

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Five-Year Follow-up of the Phase I/II Discontinuation Trial of Imatinib after Pioglitazone (EDI-PIO) in Chronic Myeloid Leukemia Patients in Deep Molecular Response

    المؤلفون: Pagnano, Katia B, Lopes, Ana Beatriz Pascoal *, Miranda, Eliana C M Cristina Martins *, Delamain, Marcia *, Duarte, Gislaine B O *, Medina, Samuel de Souza *, Pericole, Fernando Vieira, Amarante, Guilherme Brasil Duffles *, Duarte, Bruno K *, Pavan, Graziele *, Toni, Isabella Macedo *, De Paula, Erich V, Souza, Carmino Antonio *

    المصدر: In Blood 15 November 2022 140 Supplement 1:9645-9646

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  9. 9
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  10. 10
    دورية
    The Prognostic Impact of HMGCLL1Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2ndGeneration Tyrosine Kinase Inhibitor (TKI) Upfront Therapy

    المؤلفون: Perusini, Maria Agustina, Kim, Taehyung Simon, Žácková, Daniela, Pagnano, Katia B, Mayer, Jiří, Pavlovsky, Carolina, Ježíšková, Ivana, Kvetková, Anežka, Jurček, Tomáš, Moiraghi, Beatriz, Varela, Ana Ines, Bianchini, Michele, Lopes, Ana Beatriz Pascoal, Duarte, Gislaine B O, Yoo, Young Seok, Souza, Carmino Antonio, Medeiros, Jessie, Lee, Hye Won, Kim, Kyoung Ha, Yi, Seong Yoon, Chang, Myung Hee, Abelson, Sagi, Kim, Dennis Dong Hwan

    المصدر: Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p6774-6775, 2p

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء